Skip to main content
Search
Search This Blog
Biopharma Over Coffee
Updates on recent goings on in the pharma, biotech and healthcare sectors.
Posts
April 24, 2026
Anti-Amyloid Drugs in Alzheimer’s: Breakthrough, Dead End, or Reimbursement Reality Check?
February 12, 2026
MFN Pricing and the “Global Launch Freeze”: A More Measured Perspective
December 08, 2025
NICE, VPAG and the UK’s new signal to pharma: Progress at last
September 19, 2025
MASH in 2025: New Therapies, New Challenges
August 07, 2025
China’s NRDL: The World’s Largest Market Access Event Is Underway
July 02, 2025
GLP-1s and the Rise of Consumer-Led Pharma: What the Obesity Market Signals for the Future of Access
May 22, 2025
Most-Favored-Nation Drug Pricing: Policy Shift or Pressure Tactic?
Newer Posts
Older Posts
Home
